Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management

Systemic sclerosis (SSc) is a complex connective tissue disease with multiple clinical and subclinical cardiac manifestations. SSc can affect most structural components of the heart, including the pericardium, myocardium, valves, and conduction system through a damaging cycle of inflammation, ischem...

Full description

Bibliographic Details
Main Authors: Peter Glynn, Sarah Hale, Tasmeen Hussain, Benjamin H. Freed
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.846213/full
_version_ 1819156831788859392
author Peter Glynn
Sarah Hale
Tasmeen Hussain
Benjamin H. Freed
author_facet Peter Glynn
Sarah Hale
Tasmeen Hussain
Benjamin H. Freed
author_sort Peter Glynn
collection DOAJ
description Systemic sclerosis (SSc) is a complex connective tissue disease with multiple clinical and subclinical cardiac manifestations. SSc can affect most structural components of the heart, including the pericardium, myocardium, valves, and conduction system through a damaging cycle of inflammation, ischemia, and fibrosis. While cardiac involvement is the second leading SSc-related cause of death, it is frequently clinically silent in early disease and often missed with routine screening. To facilitate identification of cardiac disease in this susceptible population, we present here a review of cardiac imaging modalities and potential uses in the SSc patient population. We describe well-characterized techniques including electrocardiography and 2D echocardiography with Doppler, but also discuss more advanced imaging approaches, such as speckle-tracking echocardiography, cardiovascular magnetic resonance imaging (CMR), and stress imaging, among others. We also suggest an algorithm for the appropriate application of these modalities in the workup and management of patients with SSc. Finally, we discuss future opportunities for cardiac imaging in SSc research to achieve early detection and to optimize treatment.
first_indexed 2024-12-22T15:59:07Z
format Article
id doaj.art-98c7494cf94f42ac9be4cdc2ff34d397
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-22T15:59:07Z
publishDate 2022-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-98c7494cf94f42ac9be4cdc2ff34d3972022-12-21T18:20:43ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-03-01910.3389/fcvm.2022.846213846213Cardiovascular Imaging for Systemic Sclerosis Monitoring and ManagementPeter Glynn0Sarah Hale1Tasmeen Hussain2Benjamin H. Freed3Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United StatesDivision of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United StatesDivision of Hospital Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United StatesDivision of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United StatesSystemic sclerosis (SSc) is a complex connective tissue disease with multiple clinical and subclinical cardiac manifestations. SSc can affect most structural components of the heart, including the pericardium, myocardium, valves, and conduction system through a damaging cycle of inflammation, ischemia, and fibrosis. While cardiac involvement is the second leading SSc-related cause of death, it is frequently clinically silent in early disease and often missed with routine screening. To facilitate identification of cardiac disease in this susceptible population, we present here a review of cardiac imaging modalities and potential uses in the SSc patient population. We describe well-characterized techniques including electrocardiography and 2D echocardiography with Doppler, but also discuss more advanced imaging approaches, such as speckle-tracking echocardiography, cardiovascular magnetic resonance imaging (CMR), and stress imaging, among others. We also suggest an algorithm for the appropriate application of these modalities in the workup and management of patients with SSc. Finally, we discuss future opportunities for cardiac imaging in SSc research to achieve early detection and to optimize treatment.https://www.frontiersin.org/articles/10.3389/fcvm.2022.846213/fullcardiovascular imagingsystemic sclerosis (scleroderma)echocardiographycardiovascular magnetic resonanacescleroderma heart disease
spellingShingle Peter Glynn
Sarah Hale
Tasmeen Hussain
Benjamin H. Freed
Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management
Frontiers in Cardiovascular Medicine
cardiovascular imaging
systemic sclerosis (scleroderma)
echocardiography
cardiovascular magnetic resonanace
scleroderma heart disease
title Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management
title_full Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management
title_fullStr Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management
title_full_unstemmed Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management
title_short Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management
title_sort cardiovascular imaging for systemic sclerosis monitoring and management
topic cardiovascular imaging
systemic sclerosis (scleroderma)
echocardiography
cardiovascular magnetic resonanace
scleroderma heart disease
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.846213/full
work_keys_str_mv AT peterglynn cardiovascularimagingforsystemicsclerosismonitoringandmanagement
AT sarahhale cardiovascularimagingforsystemicsclerosismonitoringandmanagement
AT tasmeenhussain cardiovascularimagingforsystemicsclerosismonitoringandmanagement
AT benjaminhfreed cardiovascularimagingforsystemicsclerosismonitoringandmanagement